Flagship Program · Platform Heritage
Thicker, fuller hair — naturally
HairGenesis® addressed pattern hair loss through a single, cohesive protocol: a nano-emulsified oral supplement working systemically alongside a topical activator delivering actives directly to the follicle. At peak, the line was sold direct to consumers on Amazon and through international distribution partners across 25 countries.
The HairGenesis® thesis
Maximum-potency nano-emulsification carries naturally-derived actives across biological barriers for follicular bioavailability — the same enhanced-delivery thesis that underpins the TrichoCyte™ program.
A multi-target botanical complex pairing 5α-reductase inhibition with anti-inflammatory phytochemicals — addressing the dual androgenic and inflammatory drivers of pattern hair loss.
At peak distribution, HairGenesis® was the #1 dermatologist-recommended nano-enabled hair growth brand — safe for women and men, used as a stand-alone protocol or alongside prescription regimens.
Mechanism and efficacy substantiated in a peer-reviewed medical journal (2011) following a University at Albany research collaboration. Registered marks: HAIRGENESIS® USPTO 3,567,177.
The product family
Generation II · Oral
Nano-Enabled Hair Growth Accelerator Oral Supplement
Advanced hair revitalizing formulation in nano-emulsified maximum potency. One bottle = one-month supply. Promotes hair growth with visible thickness and scalp coverage — safe for women and men.
Topical
Botanically-derived topical activator
A leave-on topical that delivers HairGenesis® actives directly to the follicle and surrounding scalp environment. Formulated to layer with the TrichoCeutical™ oral supplement for systemic + topical coverage.
In real life
The science
Before HairGenesis® existed, no scientifically validated, demonstrably proven, naturally-based hair loss treatment was on the market. The HairGenesis® formulation — refined over seven generations — combines targeted DHT blockade with anti-inflammatory botanical compounds in a nano-emulsified delivery system. Mechanism and efficacy were substantiated in a peer-reviewed medical journal in 2011, following a research collaboration with the University at Albany.
Commercial record
HairGenesis® was distributed in 25 countries and generated $100M+ in lifetime retail and wholesale revenue, with $20M+ annually at peak. Its mechanism, clinical foundation, and delivery thesis carry forward into the TrichoCyte™ program and continue to inform the platform's active research and licensing initiatives.